ProHealth me-cfs Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|

Trending News

A Commercially Available Probiotic Reduces Chronic Fatigue Syndrome’s Inflammation—Should we offer t...

SURVEY RESULTS: What Name Would YOU Choose for CFS?

Simmaron’s Spinal Fluid Study Finds Dramatic Differences in Chronic Fatigue Syndrome

Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients

The Countess of Mar, Medical Politics, and ME/CFS

What were your first symptoms of ME/CFS?

Life for a Young Person with M.E.

ProHealth's 2014 Advocate of the Year – Ryan Prior

Cultivating Self-Compassion

Autoimmune Organization Makes Urgent Call For Fatigue Research

 
Print Page
Email Article

DEA Proposes 90-day Painkiller Prescriptions

  [ 1203 votes ]   [ Discuss This Article ]
By Editor • www.ProHealth.com • September 18, 2006


Currently, physicians prescribing a “Schedule II” controlled painkiller such as codeine or Oxycontin are required to limit any prescription to a 30-day supply – technically requiring patients with serious chronic pain to return for repeated office visits. But as of September 5, 2006, the U.S. Drug Enforcement Administration (DEA) proposed a change in the rule that would increase Schedule II prescriptions to 90 days. The proposed change is intended to help physicians serve their patients’ legitimate pain control needs more cost-efficiently – in response to written expressions of concern from many doctors, according to the DEA. Also, the agency recognizes this would ease the minds of doctors who take advantage of a “loophole” in the current rule for selected patients: They may be issuing more than one 30-day prescription in the same office visit, since the rule does not explicitly prohibit this. "Today's policy statement reaffirms that DEA wants doctors to treat pain as is appropriate under accepted medical community standards," said DEA Administrator Karen Tandy. The proposal is subject to a 60-day public comment period. Individuals or organizations that wish to submit comments may find contact information at http://www.deadiversion.usdoj.gov/fed_regs/rules/2006/fr0906.htm



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Vitamins and Supplements

Featured Products

MitoQ® MitoQ®
Powerful Antioxidant Support to Mitochondria
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 your brain needs for detox & sharpness

Natural Remedies

Coenzyme Q10 - The Energy Maker Coenzyme Q10 - The Energy Maker
"It's Not Easy Being Green" - But It Is Healthy
Milk Thistle: Trusted Support for Health & Healing in a Toxic World Milk Thistle: Trusted Support for Health & Healing in a Toxic World
Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging
Nutrients to Combat the Modern Stress Epidemic Nutrients to Combat the Modern Stress Epidemic

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS Diagnosis
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE  |  PRIVACY
CONTACT US
LIBRARY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing